Aurinia Pharmaceuticals AUPH Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $34.36M-83.7% | $210.79M+568% | $31.55M+46.7% | $21.51M-7.8% | $23.34M+1,534% | ||
| $4.82M-1.0% | $4.86M0.0% | $4.87M0.0% | $4.86M+0.2% | $4.86M-0.1% | ||
| -$866K-113% | $6.73M+13.7% | $5.92M+8.8% | $5.44M+260% | -$3.41M-138% | ||
| $32.56M-28.7% | $45.67M+2.7% | $44.45M+0.5% | $44.24M+3,303% | $1.3M-95.7% | ||
| -$18.08M+50.8% | -$36.76M— | —— | —— | $31.03M-20.9% | ||
| $36.17M— | $0-100% | $8.67M-79.6% | $42.56M-9.3% | $46.92M+115% | ||
| -$53.69M-2,742% | -$1.89M+82.0% | -$10.49M+76.4% | -$44.39M+10.0% | -$49.34M-114% | ||
| -$39.21M— | —— | —— | -$13.43M+21.0% | -$17.01M-137% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Aurinia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.